If you choose to share or reference this research, please include a link attributing the original work to ZipHealth.
Current Opinion in Endocrinology, Diabetes, and Obesity, 29 (6), 554-559
Disproportionality signals for IGE All five GLP-1RAs had statistically significant reporting odds ratios (RORs) for IGE: Semaglutide: ROR 24.8 Dulaglutide: ROR 14.7 Liraglutide: ROR 13.7 Exenatide: ROR 5.4 Tirzepatide: ROR 18.3 This analysis confirms that these drugs are significantly more likely to be reported in conjunction with IGE compared to other medications
This applies regardless of peptide type, dosage, or timing
"Understanding the Impact of Different Doses of Reducose Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal." Nutrients
However, stopping treatment can lead to a return of appetite and changes in blood sugar control, which some people notice as symptoms rather than true withdrawal